12 Apr 2016
Clariant and South Korean BioSpectrum agree strategic partnership
- BioSpectrum is a leading provider of natural active ingredients for Personal Care with strong scientific capabilities in bioassay and claim substantiation
- Clariant will become anchor shareholder and exclusive global distributor
- Strategic partnership will combine Biospectrum’s research strengths with Clariant’s formulations expertise and global presence
Muttenz, April 12, 2016 – Clariant, a world leader in specialty chemicals, signed an agreement to acquire a 17 % share in BioSpectrum, Inc (“BioSpectrum”). Headquartered in South Korea, BioSpectrum is a leading developer and supplier of specialty active cosmetics’ ingredients derived from Asia’s diverse flora which have proven benefits for humans.
Currently a family-owned business, BioSpectrum will remain an independently managed company. Clariant will leverage its global sales and innovation network to market BioSpectrum’s product portfolio of active ingredients worldwide, with the exception of Korea.
“The transaction will allow us to expand in the strategically important and growing global markets for Personal Care applications. Our investment in BioSpectrum will give us further access to highly innovative active ingredients based on renewable raw materials. This corresponds to a growing consumer demand for natural cosmetic ingredients, not only in the emerging markets of Asia but worldwide”, said Hariolf Kottmann, CEO of Clariant.
Christian Vang, Head of Business Unit Industrial & Consumer Specialties (BU ICS) at Clariant, commented: “We are pleased about the strategic partnership with BioSpectrum. The transaction will further enhance our earlier investment in the partnership with Beraca in Latin America and leverages on our global customer platform through exclusive distributorship. This strategic investment strengthens and significantly enlarges Clariant’s active ingredient portfolio, reinforcing our ability to deliver a comprehensive range of natural, sustainable and effective formulations to the Personal Care industry.”
Dr. Deok-Hoon Park, CEO of BioSpectrum, added: “This partnership with Clariant will be a key step in BioSpectrum’s growth. We will have a strong partner on-board supporting our fast and ambitious expansion plans and we foresee tremendous innovation synergies that will lead us to create more value for customers around the world.”
BioSpectrum is renowned for its experience in researching and developing natural raw materials that can be used in skin and hair care products. The company has strong scientific capabilities in bioassay, efficacy testing and claim substantiation,which allows the design and development of high-quality actives ingredients for the cosmetics industry. All of the ingredients are based on state-of-the-art technology and have been widely tested and developed to meet the demands and trends of the cosmetics industry.
BioSpectrum’s portfolio of functional ingredients is derived from natural products and extracts from exotic Asian plants, in particular those found on the South Korean Jeju Island – an isolated mountain formed by volcanic eruption and featuring over 1,800 plant species. Its formulation ingredients include active compounds offering moisturizing, whitening, anti-aging, wound healing, anti-acne, skin soothing, anti-inflammation, anti-dandruff, detoxification and body slimming effects.
Reader enquiries
Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
Notes for editors
Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On 31 December 2015 the company employed a total workforce of 17’213. In the financial year 2015, Clariant recorded sales of CHF 5.807 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: increase profitability, reposition portfolio, add value with sustainability, foster innovation and R&D, and intensify growth.
Related images

The project team working together for the strategic partnership (from left to right): Stephan Lynen, Head of Regional Business Line Asia BU ICS; Dr. Deok-Hoon Park, CEO of BioSpectrum; Christian Vang, Head of Clariant BU ICS; Dr. Younghyun Kim, Head of Sales and Marketing of BioSpectrum; Guido Appl, Head of Sales & Application Personal Care and Industrial & Home Care Asia-Pacific Region.
(Photo: Clariant)
Related documents
Clariant and South Korean BioSpectrum agree strategic partnership
Editorial enquiries
Carsten Seum
Clariant International Ltd
Claudia Kamensky
Clariant International Ltd
claudia.kamensky@clariant.com
Stefanie Nehlsen
Clariant International Ltd
stefanie.nehlsen@clariant.com
Anja Pomrehn
Investor Relations
Clariant International Ltd
Steven Massheder
Investor Relations
Clariant International Ltd